Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform
Published . Updated .
Fintel reports that on September 23, 2026, Oppenheimer initiated coverage of Collegium Pharmaceutical (NASDAQGS:COLL) (DB:354) with a Outperform recommendation.Prior to this rating action, the stock closed at $22.78 on September 22, 2026. Collegium Pharmaceutical's stock price ha
Directly affected
- COLL Collegium Pharmaceutical
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 23, 2026, Oppenheimer initiated coverage of Collegium Pharmaceutical (NASDAQGS:COLL) (DB:354) with a Outperform recommendation.Prior to this rating action, the stock closed at $22.78 on September 22, 2026.…
Source: Nasdaq Markets
The price since 23 Sep 2026: Acadia Healthcare (ACHC) versus the S&P 500
Since the first closing price after “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” Acadia Healthcare (ACHC) is +8.55%. The S&P 500 fund (SPY) is -0.09% over the same days, a +8.64% difference versus the market.
Filings that name Acadia Healthcare (ACHC) around 23 Sep 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 6 days after publication, inside 30 days. The filing is listed beside the story “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform.”
- Donald J Trump sell Collegium Pharmaceutical (COLL) ($15,001 - $50,000). That is 23 days before publication, inside 30 days. The filing is listed beside the story “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Acadia Healthcare (ACHC)
Companies mentioned with this story
- ACHC Acadia Healthcare
In “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 23 Sep 2026 story “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform.” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
In “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- COLL Collegium Pharmaceutical
In “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” Collegium Pharmaceutical (COLL) is linked, with no stored direction, medium confidence. Reason on file: GA selected COLL as a RELATED security because its canonical security name directly matches this event's themes: pharmaceutical, collegium. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC)
On 23 Sep 2026, “Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform” is the story that connects Acadia Healthcare (ACHC) to this story.
Acadia Healthcare (ACHC) is on the page because GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Ascendis Pharma A/S (ASND), is listed for a different reason: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Acadia Healthcare (ACHC)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. ATYR traded between 0.17 and 0.41 across 20 sessions. The latest close on file is 0.17.
What the saved facts support for Acadia Healthcare (ACHC)
46 out of 100
“Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.